Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Deciphering Metabolic Processes Regulating the Inhibition of Tumour-Associated Natural Killer Cells.

FY 2019-20

Summary
"The immune system is composed of cellular constituents capable of defending the body from diseases, including cancer. Cancer occurs when cells proliferate uncontrollably and consequently affect organ functions. In absence of clinical treatments, this disease is highly fatal. Hence, cancer immunotherapy is a promising treatment option where an individual's own immune cells are programed to kill cancerous cells in an effective manner. Natural killer (NK) cells are a subset of immune cells capable of inducing cytotoxicity against malignancies, meanwhile sparing host tissues when activated. Nonetheless, regardless of their promising potential, NK cells have rather been limited in clinical pursuits against solid tumours, mostly due to the inhibition rendered by the tumour microenvironment. Therefore, it is crucial to decipher key regulatory pathways exploited by tumours that cause this modulation. Cellular metabolism has been shown to play a critical effect with NK cell functions, but the metabolic pathways leading to reduced cytotoxicity among tumour-associated NK cells have not been elucidated. Hence, the fundamental metabolic pathways that render NK cell inhibition are important to understand as they enable us to unleash maximal NK cell cytotoxicity against malignant cells in the hostile tumour microenvironment to effectively treat cancer. Such an understanding may allow for enhanced clinical treatments to ultimately save millions of lives among those diagnosed with this fatal disease."
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
428776
Name
El-Sayes Abdullah
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Deciphering Metabolic Processes Regulating the Inhibition of Tumour-Associated Natural Killer Cells.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Cellular Metabolism; Immunology; Immunosuppression; Immunotherapy; Microenvironment; Natural Killer Cells
Abstract
"The immune system is composed of cellular constituents capable of defending the body from diseases, including cancer. Cancer occurs when cells proliferate uncontrollably and consequently affect organ functions. In absence of clinical treatments, this disease is highly fatal. Hence, cancer immunotherapy is a promising treatment option where an individual's own immune cells are programed to kill cancerous cells in an effective manner. Natural killer (NK) cells are a subset of immune cells capable of inducing cytotoxicity against malignancies, meanwhile sparing host tissues when activated. Nonetheless, regardless of their promising potential, NK cells have rather been limited in clinical pursuits against solid tumours, mostly due to the inhibition rendered by the tumour microenvironment. Therefore, it is crucial to decipher key regulatory pathways exploited by tumours that cause this modulation. Cellular metabolism has been shown to play a critical effect with NK cell functions, but the metabolic pathways leading to reduced cytotoxicity among tumour-associated NK cells have not been elucidated. Hence, the fundamental metabolic pathways that render NK cell inhibition are important to understand as they enable us to unleash maximal NK cell cytotoxicity against malignant cells in the hostile tumour microenvironment to effectively treat cancer. Such an understanding may allow for enhanced clinical treatments to ultimately save millions of lives among those diagnosed with this fatal disease."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
El-Sayes, Abdullah
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~